Search for other papers by Qing Zhou in
Google Scholar
PubMed
Search for other papers by Li Yong Zhang in
Google Scholar
PubMed
Search for other papers by Mei Feng Dai in
Google Scholar
PubMed
Search for other papers by Zhen Li in
Google Scholar
PubMed
Search for other papers by Chao Chun Zou in
Google Scholar
PubMed
Search for other papers by Hui Liu in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism has been defined as an elevated serum thyroid-stimulating hormone (TSH) with normal free thyroxine levels ( 1 ). Despite maintaining normal thyroid hormone levels, patients with subclinical
Search for other papers by Xin He in
Google Scholar
PubMed
Search for other papers by Qin Yan in
Google Scholar
PubMed
Search for other papers by Chazhen Liu in
Google Scholar
PubMed
Search for other papers by Zhengyuan Wang in
Google Scholar
PubMed
Search for other papers by Ping Liao in
Google Scholar
PubMed
Search for other papers by Tong Liu in
Google Scholar
PubMed
Search for other papers by Zehuan Shi in
Google Scholar
PubMed
Search for other papers by Qi Song in
Google Scholar
PubMed
Search for other papers by Xueying Cui in
Google Scholar
PubMed
Search for other papers by Wenjing Wang in
Google Scholar
PubMed
Search for other papers by Jiajie Zang in
Google Scholar
PubMed
-positive women without thyroid disease history and goiters. We defined overt hypothyroidism as TSH concentration over the 97.5th percentile with an FT4 concentration below the 2.5th percentile. Subclinical hypothyroidism was defined as TSH concentration above
Search for other papers by Ning Yuan in
Google Scholar
PubMed
Search for other papers by Jianbin Sun in
Google Scholar
PubMed
Search for other papers by Xin Zhao in
Google Scholar
PubMed
Search for other papers by Jing Du in
Google Scholar
PubMed
Search for other papers by Min Nan in
Google Scholar
PubMed
Search for other papers by Qiaoling Zhang in
Google Scholar
PubMed
Search for other papers by Xiaomei Zhang in
Google Scholar
PubMed
Introduction Maternal subclinical hypothyroidism (SCH), which is defined as an increased thyroid-stimulating hormone (TSH) concentration beyond the upper limit of the pregnancy-specific reference range and a normal free-thyroxine (FT4
Search for other papers by Bogumila Urgatz in
Google Scholar
PubMed
Search for other papers by Kris G Poppe in
Google Scholar
PubMed
reproduction also proposes 4.0 μIU/mL as an upper limit to the TSH reference range, unless a locally derived reference range has a higher value ( 10 ). As in other settings, the diagnosis of subclinical hypothyroidism (SCH) is made when TSH is above the upper
Search for other papers by Xiaoya Zheng in
Google Scholar
PubMed
Search for other papers by Heng Xiao in
Google Scholar
PubMed
Search for other papers by Jian Long in
Google Scholar
PubMed
Search for other papers by Qiang Wei in
Google Scholar
PubMed
Search for other papers by Liping Liu in
Google Scholar
PubMed
Search for other papers by Liping Zan in
Google Scholar
PubMed
Search for other papers by Wei Ren in
Google Scholar
PubMed
(ACR TI-RADS) guidelines (2017) ( 12 ). Definition of thyroid dysfunction The diagnosis of thyrotoxicosis was defined as a TSH value <0.56 µIU/mL with (overt thyrotoxicosis) or without (subclinical thyrotoxicosis) elevated FT3 or FT4 levels. The
Search for other papers by Till Ittermann in
Google Scholar
PubMed
Department of Zoology, Islamia College Peshawar (CU), Peshawar, Pakistan
Search for other papers by Rehman Mehmood Khattak in
Google Scholar
PubMed
Search for other papers by Marcello R P Markus in
Google Scholar
PubMed
Search for other papers by Jens-Peter Kühn in
Google Scholar
PubMed
Search for other papers by Marie-Luise Kromrey in
Google Scholar
PubMed
Search for other papers by Giovanni Targher in
Google Scholar
PubMed
Search for other papers by Antje Steveling in
Google Scholar
PubMed
DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, University Medicine, Greifswald, Germany
Search for other papers by Matthias Nauck in
Google Scholar
PubMed
Search for other papers by Henry Völzke in
Google Scholar
PubMed
inconsistent findings regarding the association between subclinical or overt primary hypothyroidism and NAFLD ( 2 , 3 ). While a significant positive association was reported between variably defined hypothyroidism and NAFLD in one meta-analysis ( 3 ), no
Search for other papers by Ayse Nurcan Cebeci in
Google Scholar
PubMed
Search for other papers by Vera Schempp in
Google Scholar
PubMed
Search for other papers by Katharina Förtsch in
Google Scholar
PubMed
Search for other papers by Bettina Gohlke in
Google Scholar
PubMed
Search for other papers by Michaela Marx in
Google Scholar
PubMed
Search for other papers by Helmuth-Guenther Dörr in
Google Scholar
PubMed
Search for other papers by Joachim Woelfle in
Google Scholar
PubMed
of 700 births in the USA ( 2 ). Patients with DS are at an increased risk of thyroid dysfunction, with overt or subclinical hypothyroidism being the most common, with an estimated frequency of 400 to 1950 in 10,000 ( 3 ). Although the incidence of GD
Search for other papers by Huixing Liu in
Google Scholar
PubMed
Search for other papers by Daoquan Peng in
Google Scholar
PubMed
Introduction Hypothyroidism, including overt and subclinical hypothyroidism is a common disease among people. The former is defined as increased serum thyroid-stimulating hormone (TSH) levels and reduced free peripheral thyroid hormone (TH
Search for other papers by Aglaia Kyrilli in
Google Scholar
PubMed
Search for other papers by Bernard Corvilain in
Google Scholar
PubMed
Department of Gynecology and Obstetrics, Copenhagen University Hospital (Hvidovre Hospital), Hvidovre, Denmark
Search for other papers by Sofie Bliddal in
Google Scholar
PubMed
Carelink Nærhospital, Roskilde, Denmark
Search for other papers by Dorthe Hansen Precht in
Google Scholar
PubMed
Institute of Clinical Medicine, Faculty of Health and Clinical Research, Copenhagen University, Copenhagen, Denmark
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Université Libre de Bruxelles (ULB), Brussels, Belgium
Search for other papers by Kris Poppe in
Google Scholar
PubMed
, depending on the iodine intake in the investigated area and the ethnic background ( 1 , 2 , 3 , 4 , 5 , 6 ). TAI is the strongest predictor for the development of subclinical or overt thyroid dysfunction in the preconception, during pregnancy, and in
Section of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Search for other papers by Ling Sun in
Google Scholar
PubMed
Search for other papers by Wenwu Zhu in
Google Scholar
PubMed
Search for other papers by Yuan Ji in
Google Scholar
PubMed
Search for other papers by Ailin Zou in
Google Scholar
PubMed
Dalian Medical University, Dalian, Liaoning, China
Search for other papers by Lipeng Mao in
Google Scholar
PubMed
Dalian Medical University, Dalian, Liaoning, China
Search for other papers by Boyu Chi in
Google Scholar
PubMed
Search for other papers by Jianguang Jiang in
Google Scholar
PubMed
Search for other papers by Xuejun Zhou in
Google Scholar
PubMed
Search for other papers by Qingjie Wang in
Google Scholar
PubMed
Search for other papers by Fengxiang Zhang in
Google Scholar
PubMed
elevated FT3 and (or) FT4 levels with reduced serum TSH level; hypothyroidism as decreased FT3 and (or) FT4 levels with increased TSH level; subclinical hyperthyroidism as decreased serum TSH level and normal serum FT4 and FT3 levels ( 22 ); and subclinical